{"component": "definition", "props": {"groups": [{"snippet": "has the meaning set forth in Article 11.", "snippet_links": [{"key": "article-11", "type": "clause", "offset": [29, 39]}], "samples": [{"hash": "I4oh1ZsGRX", "uri": "/contracts/I4oh1ZsGRX#catalent-ip", "label": "Commercial Supply Agreement (Acadia Pharmaceuticals Inc)", "score": 37.1533196441, "published": true}, {"hash": "4s8Mf83f0Pj", "uri": "/contracts/4s8Mf83f0Pj#catalent-ip", "label": "Manufacturing Preparation and Commercial Supply Agreement (Avadel Pharmaceuticals PLC)", "score": 35.1601638794, "published": true}, {"hash": "hZ9oMuV98yY", "uri": "/contracts/hZ9oMuV98yY#catalent-ip", "label": "Commercial Supply Agreement (Supernus Pharmaceuticals, Inc.)", "score": 32.5947990417, "published": true}], "size": 20, "hash": "c836f4cf857772e0b1bcf79940a0cf2e", "id": 1}, {"snippet": "means all Intellectual Property and embodiments thereof owned by or licensed to Catalent as of the date hereof or developed by Catalent other than in connection with this Agreement; \u201cInvention\u201d means any Intellectual Property developed by either Party or jointly by the Parties in connection with this Agreement (including all Change Orders under this Agreement); [* * *].", "snippet_links": [{"key": "intellectual-property-and", "type": "clause", "offset": [10, 35]}, {"key": "owned-by", "type": "definition", "offset": [56, 64]}, {"key": "date-hereof", "type": "clause", "offset": [99, 110]}, {"key": "in-connection-with", "type": "clause", "offset": [147, 165]}, {"key": "this-agreement", "type": "clause", "offset": [166, 180]}, {"key": "by-either-party", "type": "clause", "offset": [236, 251]}, {"key": "jointly-by-the-parties", "type": "clause", "offset": [255, 277]}, {"key": "change-orders", "type": "definition", "offset": [327, 340]}], "samples": [{"hash": "fsi9uq4oXmO", "uri": "/contracts/fsi9uq4oXmO#catalent-ip", "label": "Zydis Development and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "lb9fnZIQAle", "uri": "/contracts/lb9fnZIQAle#catalent-ip", "label": "Zydis Development and License Agreement (Biohaven Pharmaceutical Holding Co Ltd.)", "score": 28.3100624084, "published": true}, {"hash": "HJY9KpJ6PL", "uri": "/contracts/HJY9KpJ6PL#catalent-ip", "label": "Zydis Development and License Agreement (Biohaven Pharmaceutical Holding Co Ltd.)", "score": 28.2635173798, "published": true}], "size": 9, "hash": "38788d7530b500fb4b0232d51583102d", "id": 2}, {"snippet": "has the meaning set forth in Section 6.1.", "snippet_links": [{"key": "section-61", "type": "clause", "offset": [29, 40]}], "samples": [{"hash": "fsi9uq4oXmO", "uri": "/contracts/fsi9uq4oXmO#catalent-ip", "label": "Zydis Development and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "lb9fnZIQAle", "uri": "/contracts/lb9fnZIQAle#catalent-ip", "label": "Zydis Development and License Agreement (Biohaven Pharmaceutical Holding Co Ltd.)", "score": 28.3100624084, "published": true}, {"hash": "HJY9KpJ6PL", "uri": "/contracts/HJY9KpJ6PL#catalent-ip", "label": "Zydis Development and License Agreement (Biohaven Pharmaceutical Holding Co Ltd.)", "score": 28.2635173798, "published": true}], "size": 4, "hash": "5fc9ad17e8642035860861b0e6bd9f1b", "id": 3}, {"snippet": "has the meaning set forth in the Development Agreement.", "snippet_links": [{"key": "the-development-agreement", "type": "clause", "offset": [29, 54]}], "samples": [{"hash": "1KfnMZC16DH", "uri": "/contracts/1KfnMZC16DH#catalent-ip", "label": "Softgel Commercial Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "5JhlwcLpyQT", "uri": "/contracts/5JhlwcLpyQT#catalent-ip", "label": "Softgel Commercial Supply Agreement (TherapeuticsMD, Inc.)", "score": 30.1553726196, "published": true}, {"hash": "fl4beoRHZn4", "uri": "/contracts/fl4beoRHZn4#catalent-ip", "label": "Softgel Commercial Supply Agreement (TherapeuticsMD, Inc.)", "score": 29.5749492645, "published": true}], "size": 3, "hash": "0882b2c12da060569daac1c3b7bf930c", "id": 4}, {"snippet": "means all intellectual property and embodiments thereof owned by or licensed to Catalent as of the date hereof or developed by Catalent other than in connection with this Agreement; \u201cInvention\u201d means any intellectual property developed by either party or jointly by the parties in connection with this Agreement; \u201cAPI Inventions\u201d means any Invention that relates [**] to the Client IP, Client\u2019s proprietary API, or Client Confidential Information; and \u201cProcess Inventions\u201d means any Invention, other than an API Invention, that relates [**] to the Catalent IP, Catalent Confidential Information or relates to developing, formulating, manufacturing, filling, processing, packaging, analyzing or testing pharmaceutical products generally. All Client IP and API Inventions shall be owned solely by Client and no right therein is granted to Catalent under this Agreement, except that Catalent shall have a non-exclusive, royalty-free license to such items solely to the extent necessary to perform its obligations under this Agreement. All Catalent IP and Process Inventions shall be owned solely by Catalent and no right therein is granted to Client under this Agreement. The parties shall cooperate to achieve the allocation of rights to Inventions anticipated herein and each party shall be solely responsible for costs associated with the protection of its intellectual property. Catalent hereby assigns to Client all of its right, title, and interest in and to any and all API Inventions.", "snippet_links": [{"key": "intellectual-property-and", "type": "clause", "offset": [10, 35]}, {"key": "owned-by", "type": "definition", "offset": [56, 64]}, {"key": "date-hereof", "type": "clause", "offset": [99, 110]}, {"key": "in-connection-with", "type": "clause", "offset": [147, 165]}, {"key": "by-either-party", "type": "clause", "offset": [236, 251]}, {"key": "jointly-by-the-parties", "type": "clause", "offset": [255, 277]}, {"key": "api-inventions", "type": "definition", "offset": [314, 328]}, {"key": "client-ip", "type": "clause", "offset": [375, 384]}, {"key": "client-confidential-information", "type": "definition", "offset": [415, 446]}, {"key": "process-inventions", "type": "definition", "offset": [453, 471]}, {"key": "relates-to", "type": "definition", "offset": [598, 608]}, {"key": "products-generally", "type": "clause", "offset": [717, 735]}, {"key": "by-client", "type": "clause", "offset": [792, 801]}, {"key": "no-right", "type": "clause", "offset": [806, 814]}, {"key": "granted-to", "type": "definition", "offset": [826, 836]}, {"key": "a-non", "type": "clause", "offset": [900, 905]}, {"key": "license-to", "type": "clause", "offset": [930, 940]}, {"key": "to-the-extent", "type": "clause", "offset": [959, 972]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [998, 1030]}, {"key": "to-client", "type": "clause", "offset": [1137, 1146]}, {"key": "the-parties-shall", "type": "clause", "offset": [1169, 1186]}, {"key": "rights-to-inventions", "type": "clause", "offset": [1226, 1246]}, {"key": "each-party", "type": "clause", "offset": [1270, 1280]}, {"key": "responsible-for", "type": "clause", "offset": [1297, 1312]}, {"key": "associated-with", "type": "definition", "offset": [1319, 1334]}, {"key": "protection-of", "type": "definition", "offset": [1339, 1352]}], "samples": [{"hash": "5ulhpUHlDiI", "uri": "/contracts/5ulhpUHlDiI#catalent-ip", "label": "Commercial Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "4iW2y2DtRCp", "uri": "/contracts/4iW2y2DtRCp#catalent-ip", "label": "Commercial Supply Agreement (Kala Pharmaceuticals, Inc.)", "score": 28.4743328094, "published": true}, {"hash": "8wcNqc4dZrO", "uri": "/contracts/8wcNqc4dZrO#catalent-ip", "label": "Commercial Supply Agreement (Kala Pharmaceuticals, Inc.)", "score": 28.4168376923, "published": true}], "size": 3, "hash": "251d2c20bf2300aed126045f2f381036", "id": 5}, {"snippet": "means all Intellectual Property and related embodiments owned by or licensed to Catalent as of the Effective Date or developed by Catalent other than in connection with this Agreement; \u201cInvention\u201d means any Intellectual Property developed by either party or jointly by the parties in connection with this Agreement; \u201cClient Inventions\u201d means [\u2026***\u2026]; and \u201cCatalent Inventions\u201d means [\u2026***\u2026]. All Client IP and Client Inventions shall be owned solely by Client and no right therein is granted to Catalent under this Agreement, except that Catalent shall have a non-exclusive, royalty-free license to Client IP and Client Inventions that is necessary for use in Processing Product solely to the extent necessary for Catalent to perform its obligations under this Agreement. [\u2026***\u2026]. All Catalent IP and Catalent Inventions shall be owned solely by Catalent and no right therein is granted to Client under this Agreement. [\u2026***\u2026]. The parties shall cooperate to achieve the allocation of rights to Inventions set forth in this Article 11, and each party shall be solely responsible for costs associated with the protection of its Intellectual Property. Each party will cause its employees or contractors who perform activities pursuant to this Agreement to enter into agreements that protect Confidential Information and enable compliance with the foregoing provisions regarding ownership of Inventions.", "snippet_links": [{"key": "intellectual-property-and", "type": "clause", "offset": [10, 35]}, {"key": "owned-by", "type": "definition", "offset": [56, 64]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [89, 113]}, {"key": "in-connection-with", "type": "clause", "offset": [150, 168]}, {"key": "by-either-party", "type": "clause", "offset": [239, 254]}, {"key": "jointly-by-the-parties", "type": "clause", "offset": [258, 280]}, {"key": "client-inventions", "type": "definition", "offset": [317, 334]}, {"key": "catalent-inventions", "type": "definition", "offset": [356, 375]}, {"key": "client-ip", "type": "clause", "offset": [396, 405]}, {"key": "by-client", "type": "clause", "offset": [450, 459]}, {"key": "no-right", "type": "clause", "offset": [464, 472]}, {"key": "granted-to", "type": "definition", "offset": [484, 494]}, {"key": "a-non", "type": "clause", "offset": [558, 563]}, {"key": "license-to-client", "type": "clause", "offset": [588, 605]}, {"key": "necessary-for", "type": "definition", "offset": [639, 652]}, {"key": "to-the-extent", "type": "clause", "offset": [686, 699]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [738, 770]}, {"key": "the-parties-shall", "type": "clause", "offset": [928, 945]}, {"key": "rights-to-inventions", "type": "clause", "offset": [985, 1005]}, {"key": "article-11", "type": "clause", "offset": [1024, 1034]}, {"key": "responsible-for", "type": "clause", "offset": [1067, 1082]}, {"key": "associated-with", "type": "definition", "offset": [1089, 1104]}, {"key": "protection-of", "type": "definition", "offset": [1109, 1122]}, {"key": "each-party-will", "type": "clause", "offset": [1150, 1165]}, {"key": "enter-into-agreements", "type": "clause", "offset": [1254, 1275]}, {"key": "confidential-information-and", "type": "clause", "offset": [1289, 1317]}, {"key": "the-foregoing", "type": "clause", "offset": [1341, 1354]}, {"key": "provisions-regarding", "type": "clause", "offset": [1355, 1375]}, {"key": "ownership-of-inventions", "type": "clause", "offset": [1376, 1399]}], "samples": [{"hash": "87gswjKANtt", "uri": "/contracts/87gswjKANtt#catalent-ip", "label": "Commercial Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "5er7CiwoJwe", "uri": "/contracts/5er7CiwoJwe#catalent-ip", "label": "Commercial Supply Agreement (Acadia Pharmaceuticals Inc)", "score": 29.1560573578, "published": true}], "size": 2, "hash": "494715d05f0a6cd8d122bacf8b979489", "id": 6}, {"snippet": "\u201cCatalent Inventions\u201d and the \u201cAuto Injector Assembly Line,\u201d each as defined in the Commercial Supply Agreement, dated June 20, 2016, by and between Catalent Belgium S.A. and Palatin", "snippet_links": [{"key": "catalent-inventions", "type": "definition", "offset": [1, 20]}, {"key": "assembly-line", "type": "definition", "offset": [45, 58]}, {"key": "commercial-supply-agreement", "type": "definition", "offset": [84, 111]}], "samples": [{"hash": "7DnImJLe0TX", "uri": "/contracts/7DnImJLe0TX#catalent-ip", "label": "License Agreement (Palatin Technologies Inc)", "score": 28.1101989746, "published": true}, {"hash": "kTo8344FWrq", "uri": "/contracts/kTo8344FWrq#catalent-ip", "label": "License Agreement (Amag Pharmaceuticals Inc.)", "score": 28.0910339355, "published": true}], "size": 2, "hash": "73534cb05fadc85a54dfc9b3fc213dd0", "id": 7}, {"snippet": "means all intellectual property and embodiments thereof owned by or licensed to Catalent as of the date hereof or developed by Catalent other than in connection with this Agreement; \u201cInvention\u201d means any intellectual property developed by either party in connection with this Agreement; \u201cAPI Inventions\u201d means any Invention that relates exclusively to the Client IP or Client\u2019s patented API; and \u201cProcess Inventions\u201d means any Invention, other than an API Invention, that relates exclusively to the Catalent IP or relates to developing, formulating, manufacturing, filling, processing, packaging, analyzing or testing pharmaceutical products generally. All Client IP and API Inventions shall be owned solely by Client and no right therein is granted to Catalent under this Agreement, except that Catalent shall have a non-exclusive, royalty-free license to such items solely to the extent necessary to perform its obligations under this Agreement. All Catalent IP and Process Inventions shall be owned solely by Catalent and no right therein is granted to Client under this Agreement. The parties shall cooperate to achieve the allocation of rights to Inventions anticipated herein and each party shall be solely responsible for costs associated with the protection of its intellectual property.", "snippet_links": [{"key": "intellectual-property-and", "type": "clause", "offset": [10, 35]}, {"key": "owned-by", "type": "definition", "offset": [56, 64]}, {"key": "date-hereof", "type": "clause", "offset": [99, 110]}, {"key": "in-connection-with", "type": "clause", "offset": [147, 165]}, {"key": "by-either-party", "type": "clause", "offset": [236, 251]}, {"key": "api-inventions", "type": "definition", "offset": [288, 302]}, {"key": "client-ip", "type": "clause", "offset": [356, 365]}, {"key": "process-inventions", "type": "definition", "offset": [397, 415]}, {"key": "relates-to", "type": "definition", "offset": [514, 524]}, {"key": "products-generally", "type": "clause", "offset": [633, 651]}, {"key": "by-client", "type": "clause", "offset": [708, 717]}, {"key": "no-right", "type": "clause", "offset": [722, 730]}, {"key": "granted-to", "type": "definition", "offset": [742, 752]}, {"key": "a-non", "type": "clause", "offset": [816, 821]}, {"key": "license-to", "type": "clause", "offset": [846, 856]}, {"key": "to-the-extent", "type": "clause", "offset": [875, 888]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [914, 946]}, {"key": "to-client", "type": "clause", "offset": [1053, 1062]}, {"key": "the-parties-shall", "type": "clause", "offset": [1085, 1102]}, {"key": "rights-to-inventions", "type": "clause", "offset": [1142, 1162]}, {"key": "each-party", "type": "clause", "offset": [1186, 1196]}, {"key": "responsible-for", "type": "clause", "offset": [1213, 1228]}, {"key": "associated-with", "type": "definition", "offset": [1235, 1250]}, {"key": "protection-of", "type": "definition", "offset": [1255, 1268]}], "samples": [{"hash": "gpZcfGa92Xa", "uri": "/contracts/gpZcfGa92Xa#catalent-ip", "label": "Commercial Manufacturing Agreement (Salix Pharmaceuticals LTD)", "score": 21.0, "published": true}, {"hash": "95Nuhbrxe2u", "uri": "/contracts/95Nuhbrxe2u#catalent-ip", "label": "Commercial Manufacturing Agreement (Salix Pharmaceuticals LTD)", "score": 21.0, "published": true}], "size": 2, "hash": "8fefbd643245fcc2c75e0637b0979243", "id": 8}, {"snippet": "means all intellectual property and embodiments thereof owned by or licensed to Catalent as of the date hereof or developed by Catalent other than in connection with this Agreement; \u201cInvention\u201d means any invention or know-how (whether patentable or not, including intellectual property rights therein, developed by either party or jointly by the parties in connection with this Agreement; \u201cClient Inventions\u201d means any Invention that relates exclusively to the Client IP or the Client\u2019s proprietary API or that is solely applicable to the Processing of the Product; and \u201cCatalent Inventions\u201d means any Invention, other than a Client Invention, that relates exclusively to the Catalent IP or relates to developing, formulating, manufacturing, filling, processing, packaging, analyzing or testing pharmaceutical products generally. All Client IP and Client Inventions shall be owned solely by Client and no right therein is granted to Catalent under this Agreement, except that Catalent shall have a non-exclusive, royalty-free license to such items solely to the extent necessary to perform its obligations under this Agreement. All Catalent IP and Catalent Inventions shall be owned solely by Catalent and no right therein is granted to Client under this Agreement, except that, to the extent that the Product incorporates or the Processing of the Product utilizes Catalent Inventions, Client shall have, and is hereby granted, a non-exclusive, worldwide, royalty-free license (including the right to grant sublicenses) to use such Catalent Inventions solely to the extent necessary for the use or sale of Product. Catalent hereby assigns to Client all Client Inventions and Client hereby assigns to Catalent all Catalent", "snippet_links": [{"key": "intellectual-property-and", "type": "clause", "offset": [10, 35]}, {"key": "owned-by", "type": "definition", "offset": [56, 64]}, {"key": "date-hereof", "type": "clause", "offset": [99, 110]}, {"key": "in-connection-with", "type": "clause", "offset": [147, 165]}, {"key": "intellectual-property-rights", "type": "definition", "offset": [264, 292]}, {"key": "by-either-party", "type": "clause", "offset": [312, 327]}, {"key": "jointly-by-the-parties", "type": "clause", "offset": [331, 353]}, {"key": "client-inventions", "type": "definition", "offset": [390, 407]}, {"key": "client-ip", "type": "clause", "offset": [461, 470]}, {"key": "applicable-to", "type": "definition", "offset": [521, 534]}, {"key": "the-processing", "type": "clause", "offset": [535, 549]}, {"key": "the-product", "type": "clause", "offset": [553, 564]}, {"key": "catalent-inventions", "type": "definition", "offset": [571, 590]}, {"key": "relates-to", "type": "definition", "offset": [691, 701]}, {"key": "products-generally", "type": "clause", "offset": [810, 828]}, {"key": "by-client", "type": "clause", "offset": [888, 897]}, {"key": "no-right", "type": "clause", "offset": [902, 910]}, {"key": "granted-to", "type": "definition", "offset": [922, 932]}, {"key": "a-non", "type": "clause", "offset": [996, 1001]}, {"key": "license-to", "type": "clause", "offset": [1026, 1036]}, {"key": "to-the-extent", "type": "clause", "offset": [1055, 1068]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [1094, 1126]}, {"key": "to-client", "type": "clause", "offset": [1234, 1243]}, {"key": "client-shall", "type": "clause", "offset": [1386, 1398]}, {"key": "the-right-to-grant-sublicenses", "type": "clause", "offset": [1488, 1518]}, {"key": "necessary-for", "type": "definition", "offset": [1573, 1586]}, {"key": "sale-of-product", "type": "clause", "offset": [1598, 1613]}], "samples": [{"hash": "5AbGglvMBb", "uri": "/contracts/5AbGglvMBb#catalent-ip", "label": "Commercial Supply Agreement (Lexicon Pharmaceuticals, Inc.)", "score": 28.3374404907, "published": true}], "size": 2, "hash": "392540b8ce36779414e0fec15863d9ae", "id": 9}, {"snippet": "means all intellectual property and embodiments thereof owned by or licensed to Catalent as of the date hereof or developed by Catalent other than in connection with this Agreement; \u201cInvention\u201d means any intellectual property developed by either party or jointly by the parties in connection with this Agreement; \u201cClient Inventions\u201d means any Invention that relates to the Client IP, Bulk Product, Product, or API; and \u201cProcess Inventions\u201d means any Invention, other than a Client Invention, that relates to the Catalent IP or developing, formulating, manufacturing, filling, processing, packaging, analyzing or testing pharmaceutical products generally. All Client IP and Client Inventions shall be owned solely by Client, and Catalent hereby assigns to Client all right, title, and interest therein. No right therein is granted to Catalent under this Agreement, except that Catalent shall have a non-exclusive, non-transferable, non-sublicenseable, royalty-free license to such items solely to the extent necessary to perform its obligations under this Agreement. All Catalent IP and Process Inventions shall be owned solely by Catalent and no right therein is granted to Client under this Agreement. Catalent shall not incorporate any Catalent IP or Process Inventions into the Product or Bulk Product or manufacturing thereof. To the extent the services require Catalent to incorporate any Catalent IP or Process Inventions into the Product or Bulk Product or the manufacturing process thereof, Catalent shall obtain Client\u2019s written consent prior to doing so, and the parties shall amend the Agreement to grant Client a non-exclusive license under and to all such Catalent IP or Process Inventions, under mutually agreeable, reasonable commercial terms.", "snippet_links": [{"key": "intellectual-property-and", "type": "clause", "offset": [10, 35]}, {"key": "owned-by", "type": "definition", "offset": [56, 64]}, {"key": "date-hereof", "type": "clause", "offset": [99, 110]}, {"key": "in-connection-with", "type": "clause", "offset": [147, 165]}, {"key": "by-either-party", "type": "clause", "offset": [236, 251]}, {"key": "jointly-by-the-parties", "type": "clause", "offset": [255, 277]}, {"key": "client-inventions", "type": "definition", "offset": [314, 331]}, {"key": "client-ip", "type": "clause", "offset": [373, 382]}, {"key": "bulk-product", "type": "definition", "offset": [384, 396]}, {"key": "process-inventions", "type": "definition", "offset": [420, 438]}, {"key": "products-generally", "type": "clause", "offset": [635, 653]}, {"key": "by-client", "type": "clause", "offset": [713, 722]}, {"key": "to-client", "type": "clause", "offset": [752, 761]}, {"key": "no-right", "type": "clause", "offset": [802, 810]}, {"key": "granted-to", "type": "definition", "offset": [822, 832]}, {"key": "a-non", "type": "clause", "offset": [896, 901]}, {"key": "license-to", "type": "clause", "offset": [964, 974]}, {"key": "to-the-extent", "type": "clause", "offset": [993, 1006]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [1032, 1064]}, {"key": "the-product", "type": "clause", "offset": [1277, 1288]}, {"key": "the-services", "type": "clause", "offset": [1345, 1357]}, {"key": "manufacturing-process", "type": "definition", "offset": [1468, 1489]}, {"key": "written-consent", "type": "clause", "offset": [1530, 1545]}, {"key": "prior-to", "type": "definition", "offset": [1546, 1554]}, {"key": "the-parties-shall", "type": "clause", "offset": [1569, 1586]}, {"key": "agreement-to", "type": "definition", "offset": [1597, 1609]}, {"key": "exclusive-license", "type": "definition", "offset": [1629, 1646]}, {"key": "reasonable-commercial-terms", "type": "definition", "offset": [1730, 1757]}], "samples": [{"hash": "b0ayee1z8SS", "uri": "/contracts/b0ayee1z8SS#catalent-ip", "label": "Commercial Supply Agreement (Phathom Pharmaceuticals, Inc.)", "score": 32.6057510376, "published": true}], "size": 1, "hash": "dae2a259b0b300cff1bfad6f3e0bde15", "id": 10}], "next_curs": "ClgSUmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIUY2F0YWxlbnQtaXAjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "has the meaning set forth in Article 11.", "title": "Catalent IP", "size": 34, "id": "catalent-ip", "examples": ["All <strong>Catalent IP</strong> and Process Inventions shall be owned solely by Catalent and except as set forth in Section 3.1 no other right therein is granted to Client under this Agreement.", "Notwithstanding the foregoing, where any Action alleges that (i) <strong>Catalent IP</strong> and/or Process Inventions and (ii) Client IP and/or Client Inventions, infringe the Intellectual Property rights of a third party, then irrespective of which Party controls the defense of such Action, the Parties will discuss in good faith how to defend such Action.", "To its knowledge, there is (i) no patent owned by a third party related to the <strong>Catalent IP</strong> used to Process Product that would be infringed or misused by performance under this Agreement, and (ii) no trade secret or other proprietary right of a third party related to the <strong>Catalent IP</strong> used to Process Product that would be infringed or misused by performance under this Agreement.", "All <strong>Catalent IP</strong> and Process Inventions shall be owned solely by Catalent and no right therein is granted to Client under this Agreement.", "Catalent shall not incorporate any <strong>Catalent IP</strong> or Process Inventions into the Product or Bulk Product or manufacturing thereof.", "All <strong>Catalent IP</strong>, Softgel Inventions and Process Inventions shall be owned solely by Catalent and no right therein is granted to Client under this Agreement.", "To the extent the services require Catalent to incorporate any <strong>Catalent IP</strong> or Process Inventions into the Product or Bulk Product or the manufacturing process thereof, Catalent shall obtain Client\u2019s written consent prior to doing so, and the parties shall amend the Agreement to grant Client a non-exclusive license under and to all such <strong>Catalent IP</strong> or Process Inventions, under mutually agreeable, reasonable commercial terms.", "No right to the <strong>Catalent IP</strong> is granted to AMAG under this Agreement.", "Catalent has all necessary authority to use the <strong>Catalent IP</strong> as contemplated by this Agreement.", "All <strong>Catalent IP</strong> and Process Inventions shall be owned solely by Catalent."], "related": [["licensed-technology", "Licensed Technology", "Licensed Technology"], ["licensee-technology", "Licensee Technology", "Licensee Technology"], ["third-party-technology", "Third Party Technology", "Third Party Technology"], ["product-technology", "Product Technology", "Product Technology"], ["developed-technology", "Developed Technology", "Developed Technology"]], "related_snippets": [], "updated": "2026-02-28T06:15:34+00:00"}, "json": true, "cursor": ""}}